Need Help?
Announcements
27 January 2025
Acknowledgment to the Reviewers of Diseases in 2024
The editorial team at Diseases extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Diseases received 1879 review reports from 1246 reviewers representing 79 countries and regions worldwide.
To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Diseases expresses its sincere gratitude through an annual acknowledgment of reviewers.
We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:
Astrida Velena | Kielan Mcalinden |
Afshan Masood | Kijin Kim |
Alejandra García-Gasca | Konda Mani Saravanan |
Alejandro Vega-Muñoz | Konstantinos Efthymakis |
Aleksandra Klisic | Konstantinos Giakoumidakis |
Alessandro Di Rienzo | Koyeli Girigoswami |
Alessia Verduri | Krzysztof Korzeniewski |
Alicia Irene Arechavala | Kuldeep Gupta |
Alireza Fakhriravari | Kuo-Hui Su |
Alireza Mohammad Karim | Laurentiu M. Pop |
Amirmohammad Khalaji | Lidija Savić |
Amit Goel | Liliang Li |
Ana Andabak Rogulj | Lorenzo Malatino |
Ana Hećimović | Luca Giannella |
Anastazia Kei | Luca Giacomelli |
Andrea Sonaglioni | Lucia Ansani |
Andreas Anestis | Lukasz Szarpak |
Andreas Müssigbrodt | Lukasz Dobrek |
Andreu Comas-Garcia | Lyudmila Pivina |
Andrew Jin | Maciej Przybyłek |
Angélica Saraí Jiménez-Osorio | Maged Tharwat Elghannam |
Angeliki Mavroidi | Mahboob Alam |
Angelos K. Sikalidis | Makoto Endo |
Anja Diem | Marat Ezhov |
Anna Alekseevna Skuredina | Marc Beltrà |
Anne Kasus-Jacobi | Marcel Henrique Marcondes Sari |
Anthony Fehr | Marco Fiore |
Anthony J. Sadler | Marcus Krüger |
Anton R. Kiselev | Margarita Ivanova |
Antonio Gidaro | María Guadalupe Frías-De-León |
Anuj Kumar | Maria Kantzanou |
Ariel Teles | Maria Trovato |
Arkalgud Ramaprasad | Marino Paroli |
Athanassios Tselebis | Mario Diplomatico |
Baihai Jiao | Martine Wallon |
Balakumar Chandrasekaran | Marzena Jezewska-Zychowicz |
Beatriz Teresita Martin Marquez | Masoud Keikha |
Bernardo Vega Crespo | Massimo Montisci |
Bernice N. Harris | Mathieu David |
Bill Primack | Matteo Conti |
Bin Du | Matteo Riccò |
Bojana B. Vidović | Maximilian Deußing |
Boleslaw Tomasz Karwowski | Meng-Yao Li |
Calin Cainap | Michael Eisenhut |
Carlos O'Connor-Reina | Michał Zarobkiewicz |
Carlos Trenado | Mieszko Wieckiewicz |
Catharina Sagita Moniaga | Miguel A. Castro Villamor |
Cesar Augusto Roque-Borda | Mihai Capilna |
Cesar Iván Avilés González | Mihalj Poŝa |
Chandrabose Selvaraj | Milica Aćimović |
Charikleia Stefanaki | Mirjana Jerkic |
Christian Wunder | Mirza Pojskic |
Christopher Kobierzycki | Mohamed Rahouma |
Claudiu N. Lungu | Mohamed Abuzaid |
Consolato Sergi | Mohammadreza Shalbafan |
Craig Horswill | Muhammad Asif Zahoor |
Cristian Mornos | Myung Goo Lee |
Cristina Capatina | Narayanaswamy Venketasubramanian |
Cyril Fersing | Narsimha Mamidi |
Daniela Braconi | Natale Calomino |
Daniele Ugo Tari | Natale Musso |
Danielle Greenberg | Natalia Kamanina |
Danijela Budimir Mršić | Neeraj Kumar Chauhan |
David A. Schwartz | Negrut Nicoleta |
Dee Wu | Nenad Pandak |
Delia Lidia Salaru | Neus Baena |
Demetrios Arvanitis | Nicola Magnavita |
Derar H. Abdel-Qader | Nicola Nante |
Dhruvesh Patel | Nitin Sampat Kamble |
Dia C. Beachboard | Nompumelelo Mkhwanazi |
Dimitris Tatsis | Omid Mirmosayyeb |
Dimosthenis Lykouras | Omid Akhavan |
Dirk W. Lachenmeier | Ozgur Karcioglu |
Doha Mohamed | Panagiotis Savvoulidis |
Dominika Guzek | Paola Di Carlo |
Dorota Formanowicz | Paolo Monardo |
Ebubekir Daglilar | Paolo Landa |
Edgar Flores-Soto | Patrícia C. Pires |
Eduardo Yoshio Nakano | Patrick Martin |
Eleuterio A. Sánchez-Romero | Paweł Glibowski |
Elias Kouroumalis | Paweł Krzyżek |
Elisabetta Tozzi | Pedro Infante-Cossio |
Emilia Migliano | Peter Michael Baptista Jardin |
Emiliano Tesoro-Cruz | Peter Timmins |
Emilio Bucio | Petri Böckerman |
Emmanouil Ioannis Kapetanakis | Pietro Pugliatti |
Erica Diani | Primrose Freestone |
Evangelos Liatsikos | Puya Dehgani-Mobaraki |
Evgeny N. Imyanitov | Qingsen Shang |
Fabio Fabbian | Rafał Watrowski |
Fabrizio Guerra | Raghunadharao Digumarti |
Farid Ahmed | Rana A. Youness |
Federica Fogacci | Ravendra P. Chauhan |
Federico Giorgi | Renata Ciccarelli |
Federico Marchesi | Renata Heisler Neves |
Fernando Ferrero | Ren-Hau Li |
Fernando P. Monroy | Reza Nedaeinia |
Flavia Leao Barbosa | Richard F. Riedel |
Flavia Mori Sarti | Richard Honeywell |
Flor H. Pujol | Rishi Jaiswal |
Flora De Conto | Ritthideach Yorsaeng |
Flora N. Balieva | Robert Eibl |
Francesco Massoni | Robert Kleszcz |
Francisco Epelde | Roberta Di Pietro |
Fumio Otsuka | Roberto Castiglione |
Fushan Tang | Roberto Giovanni Carbone |
Gang Li | Roberto Scarpioni |
George Koulaouzidis | Roehe Michel Roehe |
George Grant | Ronit Vogt Sionov |
Georgiana Bianca Constantin | Roxana Liana Lucaciu |
Gerard Goh | Sagar Sudam Thorat |
Ghulam Jilany Khan | Sagarika Biswas |
Gianluca Rizzo | Said El-Ashker |
Gilberto Gonzalez-Parra | Salvatore Pezzino |
Giovanni La Penna | Sandeep Kumar Mishra |
Giuliano Tocci | Sandro Jose Ribeiro Bonatto |
Giuseppe Di Martino | Santiago Pedro Aubourg Martínez |
Giuseppina Rea | Satheesha B. Nayak |
Godfrey Mutashambara Rwegerera | Satoru Munakata |
Gudrun Elisabeth Koehl | Seamus O'Reilly |
Guillermo Alberto Keller | Semer Maksoud |
Gulali Aktas | Sergei Boichuk |
Gustavo Fernandes | Sergey Sedykh |
Halim Işsever | Seyed Ahmad Naseri Alavi |
Halina Tkaczenko | Shaher Hamaideh |
Hamid Tebyaniyan | Shalimar |
Hamidreza Karimi-Sari | Shaonong Dang |
Harald Krentel | Shehwaz Anwar |
Henry Atkinson | Shek Man Chim |
Henry Lukaski | Sherien Eldaly |
Hitesh Chopra | Shweta Tripathi |
Hitoshi Tonomura | Silvia Hofer |
Hongmei Dong | Simone Brogi |
Hosoon Choi | Singh Kumar Avishek |
Hussam Ali | Siyong Kim |
Hwei Jene Ng | Somya Agrawal |
Ibrahim Gosadi | Stefano Filippi |
Ignazio Gaspare Vetrano | Stefano Francesco Crinò |
Ina Sevic | Stephanie Dauth |
Ioannis Ventoulis | Subbarao V. Madhunapantula |
Irena Ilic | Sueli Fumie Yamada-Ogatta |
Irina Vlasova-St. Louis | Sulev Koks |
Irma González-Curiel | Sushant Covaris |
Ivanildo Sousa | Syed Nabil |
Ivo Lopes | Tadahisa Sugiura |
James Patrick O'Connor | Tajamul Hussain |
Jacek Cholewicki | Takemichi Fukasawa |
Jacek Piątek | Tania Colasanti |
Jader De Oliveira | Tarek M.A. Abdel-Fatah |
Jaishree Raman | Terenzio Cosio |
Javier Martínez Torres | Tetyana Chumachenko |
Jean-Marie Exbrayat | Tomislav Tosti |
Jeni Prosperi | Torbjörn Ledin |
Jenna E. Coalson | Ulf Schött |
Jeremy Marks | Ursula Panzner |
Jia-Feng Chang | Vaitsa Giannouli |
Jialing Lin | Vajir Malek |
Jihua Guo | Valentina Lancellotta |
Jiří Remr | Valerio Leoni |
Joan-Lluis Vives Corrons | Vance Nielsen |
Joanna Dzido | Vasiliki Karava |
João Paulo Saraiva Santos | Vasudevan Gowthaman |
John K. Triantafillidis | Víctor José González Ramallo |
John Lalith Charles Richard | Victoria Bunik |
John P.A. Lusingu | Vijay Patel |
Jonathan Karp | Vincent Ho |
Jong-Hwa Jang | Wei Boon Yap |
Jorge Feito | Wei-Ting Lin |
Jose Martinez-Hernandez | Wilhelm Peter Mistiaen |
José Antonio De Paz | Wing Shing Ho |
José Artur Bogo Chies | Wioletta Rozpędek-Kamińska |
Jose-Luis Pérez-Castrillón | Wissem Mnif |
Josip Andelo Borovac | Wladimir Bocca Vieira de Rezende Pinto |
Juan Alberto Castillo-Garit | Xian-Zhi Li |
Juan Francisco Leon | Yanka Dimitrova Karamalakova |
Juan de los Toyos | Yaoxiang Li |
Juandy Jo | Yasin Tülüce |
Judy Gopal | Yi-Qing Yang |
Karel Van Den Bosch | Yong Jin |
Karen Bohmwald | Yongbo Liang |
Karolina Akinosoglou | Yongsheng Chen |
Katarina Sebekova | Zehuan Liao |
Katsuya Kitamura | Zeljko Prijovic |
Kay-Dietrich Wagner | Zhenbo Xu |
Kazuhiko Hashimoto | Zhengwei Huang |
Keita Kai | Zhiwei Yang |
Keith Rochfort | Zoran Gluvic |
Kenneth N. White | Zoran Todorovic |
Keren Dopelt | Zornitsa Gancheva Kamenarska |
Khalid Muhammad |
26 January 2025
World Neglected Tropical Diseases Day—30 January 2025
On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.
We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.
“A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System”
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568
“Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria”
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047
“Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview”
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050
“Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review”
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203
“Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review”
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205
“False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report”
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100
“Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks”
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022
“Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission”
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014
“Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study”
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425
“DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction”
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624
“Global Fight against Malaria: Goals and Achievements 1900–2022”
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680
“Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil”
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469
“Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice”
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128
“Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective”
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285
“Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming”
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015
“Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania”
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658
Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition” |
Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases” |
Special Issue: “One Health and Neglected Zoonotic Diseases” |
Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota” |
26 January 2025
Meet Us at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery, 20–22 February 2025, Yamaguchi, Japan
Conference: The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery
Date: 20–22 February 2025
Location: Yamaguchi, Japan
MDPI will be attending the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery as an exhibitor which will be held from 20 to 22 February 2025. We invite researchers from different fields of study to share their ideas with us.
The 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery will be held in Shimonoseki. The theme of the annual meeting is “Beyond The WAVE! Go on and overcome!”. This meeting theme aims to help surgeons overcome difficulties and challenges during their growth and development. The entire meeting will be split into five areas of coronary artery disease—valvulopathy, aortic disease, congenital malformations, and peripheral vascular disease—each of which has its own Program Committee that has put together the primary sessions. Attending the meeting is important for academic learning at the venue, but exchanging views with other participants, obtaining new information, and engaging in conversations is also extremely meaningful.
The following MDPI journals will be represented at the conference:
- JCM;
- JCDD;
- Reports;
- Diseases;
- Clinics and Practice;
- Surgeries;
- Surgical Techniques Development;
- Complications;
- JVD;
- Pathophysiology;
- JPM;
- Anatomia;
- Antioxidants.
If you are planning to attend the above conference, please do not hesitate to visit booth #27 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. We warmly encourage researchers from different backgrounds to visit and share their ideas with us.
For more information about the conference, please visit the following website: https://www.congre.co.jp/jscvs2025/en/index.html.
24 January 2025
World Leprosy Day 2025—Unite. Act. Eliminate.
World Leprosy Day is a global awareness initiative aimed at shedding light on the ongoing challenges posed by leprosy, a curable disease that still affects thousands annually. This day also emphasizes the collective responsibility to eliminate stigma, promote dignity, and ensure equitable access to healthcare for individuals and communities impacted by leprosy. It serves as a reminder of the importance of early detection, effective treatment, and global cooperation in addressing this neglected tropical disease.
In recognition of World Leprosy Day 2025, we invite you to explore selected articles, Special Issues, and journals such as Pathogens, Microbiology Research, Diseases, Healthcare and Tropical Medicine and Infectious Disease. By fostering collaboration and sharing knowledge, we aim to inspire positive action and contribute to a future where leprosy is no longer a public health concern, and all individuals affected by it can live with dignity and acceptance.
|
“The Safety, Acceptability, and Feasibility of Single-Dose Rifampicin as Post-Exposure Chemoprophylaxis for Contacts of Leprosy Patients in Togo: A Mixed-Method Sequential Explanatory Study”
by Akila Wimima Bakoubayi, Falapalaki Haliba, Wendpouiré Ida C. Zida-Compaore, P’tanam P’kontème Bando, Yao Rodion Konu, Abissouwèssim Egbare Tchade, Kodjo Akpadja, Kamevor Alaglo, Maweke Tchalim, P’niwè Patchali et al.
Trop. Med. Infect. Dis. 2024, 9(11), 276; https://doi.org/10.3390/tropicalmed9110276
“Genomic and Phenotypic Variations Among Thai-53 and Mycobacterium leprae Clinical Isolates: Implications for Leprosy Pathogenesis and Research”
by Tiago Araujo Gomes, Tatiana Pereira da Silva, Edson Machado, Sidra Ezidio Gonçalves Vasconcelos, Bruno Siqueira Mietto, Daniela Ferreira de Faria Bertoluci, Patricia Sammarco Rosa, Roberta Olmo Pinheiro, Philip Noel Suffys, Letícia Miranda Santos Lery et al.
Pathogens 2024, 13(11), 986; https://doi.org/10.3390/pathogens13110986
“Human Skin as an Ex Vivo Model for Maintaining Mycobacterium leprae and Leprosy Studies”
by Natália Aparecida de Paula, Marcel Nani Leite, Daniele Ferreira de Faria Bertoluci, Cleverson Teixeira Soares, Patrícia Sammarco Rosa and Marco Andrey Cipriani Frade
Trop. Med. Infect. Dis. 2024, 9(6), 135; https://doi.org/10.3390/tropicalmed9060135
“Training and Active Case Detection to Prevent Leprosy: Effect on Knowledge, Attitude and Skills of Health Workers on Early Diagnosis of Leprosy in a Leprosy Hotspot District in Ethiopia”
by Ephrem Mamo, Dareskedar Tsehay, Seid Hassen, Solomon Getahun, Addis Mengiste, Beletshachew Tadesse, Tesfaye Tadesse, Mengestu Legesse and Kidist Bobosha
Trop. Med. Infect. Dis. 2024, 9(3), 51; https://doi.org/10.3390/tropicalmed9030051
“Self-Care Ability and Life Quality of Cured Leprosy Patients: The Mediating Effects of Social Support”
by Li Xu, Guangjie Jin, Xiang Li, Yuting Shao,Yunhui Li and Lianhua Zhang
Healthcare 2023, 11(23), 3059; https://doi.org/10.3390/healthcare11233059
“Immunohistochemical Characterization of M1, M2, and M4 Macrophages in Leprosy Skin Lesions”
by Tatiane Costa Quaresma, Lívia de Aguiar Valentim, Jorge Rodrigues de Sousa, Tinara Leila de Souza Aarão, Hellen Thais Fuzii, Maria Irma Seixas Duarte, Juarez de Souza and Juarez Antônio Simões Quaresma
Pathogens 2023, 12(10), 1225; https://doi.org/10.3390/pathogens12101225
“Potassium-Incorporated Titanium Oxide Nanoparticles Modulate Human Dendritic Cell Immune Response to Mycobacterium leprae”
by Sam Warren, So Yoon Lee, Jose Barraga, Piya Kositangool, Hatsuko Yoshikubo and Jorge Cervantes
Microbiol. Res. 2023, 14(2), 787-797; https://doi.org/10.3390/microbiolres14020055
“Meaningful Engagement of Persons Affected by Leprosy in Research: An Exploration of Its Interpretation, Barriers, and Opportunities”
by Laura de Groot, Anna T. van ‘t Noordende, Mathias Duck, Joshua Oraga, Sarju Sing Rai, Ruth M. H. Peters and Nienke Veldhuijzen
Trop. Med. Infect. Dis. 2023, 8(1), 52; https://doi.org/10.3390/tropicalmed8010052
22 January 2025
Meet Us at the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, 2 March 2025, Osaka, Japan
Conference: The 102nd Annual Meeting for the Osaka Society for Dialysis Therapy
Date: 2 March 2025
Location: Osaka, Japan
MDPI will be attending the 102nd Annual Meeting for the Osaka Society for Dialysis Therapy, which will be held on 2 March 2025, as an exhibitor, and we welcome researchers from various backgrounds to visit and share their latest ideas with us.
In the future, it is expected that the introduction of generative AI, IoT, and robotics will enhance medical services, expand and strengthen research support systems, and further improve medical technologies. The Osaka Dialysis Research Society has the mission of achieving sustainable development in the fields of dialysis and chronic kidney disease treatment, thereby improving the quality of life (QOL) and prognosis of patients undergoing dialysis and those with chronic kidney disease. To fulfill this mission, they aim to strive for the introduction of the latest research and technologies in dialysis therapy and chronic kidney disease treatment, as well as the education, professional development, and training of medical practitioners.
The following MDPI journals will be represented at the conference:
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://osdt.jp/102th/.
21 January 2025
MDPI’s Newly Launched Journals in December 2024
Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.
We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.
Please feel free to browse and discover more about the new journals below.
Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
|
Prof. Dr. Zhaoyang Dong |
energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage View journal scope | Submit an article |
Prof. Dr. Yang-Hui He 1. London Institute for Mathematical Sciences, Royal Institution, UK 2. University of Oxford, UK Editorial | View inaugural issue |
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory; convex geometry View journal scope | Submit an article |
|
Dr. Michel Planat Université de Franche-Comté, France Editorial | View inaugural issue |
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets View journal scope | Submit an article |
|
Prof. Dr. Rashid Al Abri 1. Sultan Qaboos University, Oman 2. Oman Medical Association, Oman Editorial | View inaugural issue |
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety View journal scope | Submit an article |
|
Prof. Dr. Ecevit Bilgili* New Jersey Institute of Technology, USA *Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration. Editorial | View inaugural issue |
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production View journal scope | Submit an article |
|
Dr. Weiyong Liu Huazhong University of Science and Technology, China Editorial | View inaugural issue |
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry View journal scope | Submit an article |
|
Prof. Dr. Manuel Pedro Rodríguez Bolívar University of Granada, Spain Editorial | View inaugural issue |
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation View journal scope | Submit an article |
|
Prof. Dr. Fei Fan Wuhan University, Wuhan 430072, China Editorial | View inaugural issue |
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice View journal scope | Submit an article |
|
Dr. Kevin Cianfaglione Université Catholique de Lille, France Editorial | View inaugural issue |
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation View journal scope | Submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee ([email protected]) if you would like to create more new journals.
17 January 2025
Meet Us at the 145th Annual Meeting of the Pharmaceutical Society of Japan, 26–29 March 2025, Fukuoka, Japan
Conference: The 145th Annual Meeting of the Pharmaceutical Society of Japan
Date: 26–29 March 2025
Location: Fukuoka, Japan
MDPI will be attending the 145th Annual Meeting of the Pharmaceutical Society of Japan as an exhibitor, which will be held from 26 to 29 March 2025, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.
The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: 1) Pharmaceutical Chemistry; 2) Pharmaceutical Physics; 3) Pharmaceutical Biology; 4) Pharmaceutical Health Science and Environmental Toxicology; 5) Pharmaceutical Health Care and Sciences; and 6) Others.
The following MDPI journals will be represented at the conference:
- Biomedicines
- Pharmaceuticals
- Pharmaceutics
- Antibiotics
- Antibodies
- Antioxidants
- CIMB
- Diseases
- Future Pharmacology
- IJERPH
- IJMS
- IJTM
- JNT
- JPM
- Marine Drugs
- Medicina
- Medicines
- Metabolites
- Psychoactives
- Sci. Pharm
- Sclerosis
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://pub.confit.atlas.jp/en/event/pharm145.
15 January 2025
Meet Us Virtually at the 1st International Online Conference on Diseases—From the Molecular to the Clinical Perspectives, 9–11 September 2025
Name: The 1st International Online Conference on Diseases
Date: 9–11 September 2025
Chair: Prof. Dr. Omar Cauli, University of Valencia, Department of Nursing, Spain
We are pleased to announce that the 1st International Online Conference on Diseases, chaired by Prof. Dr. Omar Cauli, will be held from 9 to 11 September 2025.
This conference aims to provide leading scientists working in the field of diseases, from the molecular to the clinical perspective, with a robust common platform through which to share and discuss the latest research and to promote the advancement of this exciting and rapidly changing field.
We hope to encourage discovery across the discipline as we cover the following themes:
S1: Infectious diseases;
S2: Nutrition and dietetics;
S3: Immune and inflammatory diseases;
S4: Geriatrics;
S5: Cardiovascular diseases;
S6: Neuropsychiatric disorders;
S7: Endocrine and metabolic disorders.
Important Deadlines:
Deadline for abstract submission: 12 May 2025;
Notification of acceptance: 23 June 2025;
Deadline for registration: 4 September 2025.
Guide for Authors:
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1297.
To register for the event for free, please click on the following link: https://sciforum.net/event/IOCD2025?section=#registration.
For more information, you may refer to https://sciforum.net/event/IOCD2025?section=#instructions.
For any enquiries regarding the event, please contact us at [email protected].
We look forward to seeing you at the 1st International Online Conference on Diseases!
7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflecting on 2024: Celebrating Our Progress and People
As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.
Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.
Looking for a new role in 2025? We have a variety of roles currently open!
Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.
These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.
On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.
Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.
“MDPI thrives because of community and collaboration”
When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.
As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.
Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.
PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.
Impactful Research
685 MDPI Editors Named Highly Cited Researchers in 2024
I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.
Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.
Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.
As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.
I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.
Inside MDPI
How MDPI / Open Access Supports Societies
MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.
Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.
Learn about how MDPI / Open Access Supports Societies.
In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.
If you would like to learn more about these services, please see the Societies website.
The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.
How long have you been at MDPI, and what was your first role?
I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team.
Do you think that perceptions of Open Access are generally accurate?
Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards.
How long have you been at MDPI, and what was your first role?
I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.
What is the most common question you get asked about the services that the Societies team provides?
For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.
For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.
Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.
Read more:
Coming Together for Science
2024 MDPI Conference Summary
Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.
The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.
2024 Event Highlights
Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.
Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’
Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’
A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.
The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.
The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.
ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.
The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.
Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.
In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.
The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.
Scheduled Events in 2025
- Smart Sustainable Cities 2025: Pioneering Novel Frontiers for Green Urban Living: 5–7 Mar 2025, online.
- International Conference on Advanced Remote Sensing (ICARS 2025): 26–28 Mar 2025, Barcelona, Spain.
- Plants 2025: From Seeds to Food Security: 31 Mar–2 Apr 2025, Barcelona, Spain.
- Symmetry 2025 - The 5th International Conference on Symmetry: 16–19 May 2025, Hangzhou, China.
- The 2nd International Conference on AI Sensors and Transducers: 29 Jul–3 Aug 2025, Bangkok, Thailand.
- The 5th International Symposium on Frontiers in Molecular Science: 26–29 Aug 2025, Kyoto, Japan.
- The 11th World Sustainability Forum: Sustainable and Resilient Cities: 2–3 Oct 2025, Barcelona, Spain.
- The Cancers 2025 and Sensors 2025 websites will soon be made public.
Closing Thoughts
Over 100 German Universities Partner with MDPI in New National Agreement
I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.
This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.
Learn more, here.
“Thank you to everyone who contributed to making this agreement a reality.”
Why is this important?
Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.
This agreement reflects our growing influence and leadership in open access publishing.
Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.
As Peter Roth, MDPI Head of Publishing, noted:
“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.”
Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:
“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform”
Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.
Chief Executive Officer
MDPI AG
6 January 2025
Meet Us at the ESCMID Global 2025, 11–15 April 2025, Vienna, Austria
MDPI will attend ESCMID Global 2025, which will take place in Vienna, Austria, from 11 April to 15 April 2025.
ESCMID Global is the largest international meeting of its kind, and it plays a pivotal role in bringing together the global scientific community to exchange knowledge, share insights, and collaborate on cutting-edge research. Last year, the conference attracted 18,599 registered participants and received more than 7,800 abstract submissions from more than 129 countries. This overwhelming response underscores the ongoing growth of the ESCMID Global community and its leadership role in the field of infections. The submissions covered a wide range of topics and allowed for the curation of an outstanding and diverse programme that showcased the latest research and innovations from leading experts in the field.
The following MDPI journals will be represented at the conference:
- JCM;
- Antibiotics;
- Diagnostics;
- Venereology;
- TropicalMed;
- Diseases;
- IJMS;
- Life;
- JPM;
- Reports;
- Medicines;
- Vaccines;
- Infectious Disease Reports;
- Clinics and Practice;
- BioMed;
- Therapeutics.
If you are planning on attending this conference, please do not hesitate to stop by our booth, K40, and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escmid.org/congress-events/escmid-global/vienna-2025/.